The findings are of functional significance, as live-cell imaging assays showed that treatment with either AR inhibitors blunted the proliferation of BRAFi-resistant melanoma cells and, at the same time, induced cell death (Fig. 8c, d). The gene discussed is AR; the disease is melanoma.